Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co Ltd    600276   CNE0000014W7

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
74.49(c) 75.1(c) 73.54(c) 72.8(c) 74.36 Last
141 140 172 476 115 277 99 762 116 944 Volume
-0.16% +0.82% -2.08% -1.01% +2.14% Change
More quotes
Financials ( CNY)
Sales 2017 13 431 M
EBIT 2017 3 610 M
Net income 2017 3 149 M
Finance 2017 6 448 M
Yield 2017 0,14%
Sales 2018 16 326 M
EBIT 2018 4 437 M
Net income 2018 3 857 M
Finance 2018 9 039 M
Yield 2018 0,16%
P/E ratio 2017 65,13
P/E ratio 2018 53,03
EV / Sales2017 14,8x
EV / Sales2018 12,0x
Capitalization 205 B
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. engages in the research and development, manufacture, and sale of drug.It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs.Its products include tablets, oral solution, and suspension of... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
01:59a JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
01/09 TG THERAPEUTICS : and Jiangsu Hengrui Medicine Announce Global License Agreement..
01/08 TG THERAPEUTICS, INC. (NASDAQ : TGTX) Files An 8-K Entry into a Material Definit..
01/05 JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
2017 JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
2017 JIANGSU HENGRUI MEDICINE CO., LTD : ex-dividend day for annual dividend
2017 JIANGSU HENGRUI MEDICINE : Hengrui Medicine c-Met ADC Wins FDA Approval for Clin..
2016 JIANGSU HENGRUI MEDICINE CO., LTD : ex-dividend day for annual dividend
2016 JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
2016 China signals price cuts for cancer drugs, imports
More news
Sector news : Pharmaceuticals - NEC
01:20a At AstraZeneca, fewer drug projects bring big productivity jump
01/18 European shares edge higher as cyclicals back in favour
01/18 ABLYNX : Largest Ablynx investor would consider improved Novo Nordisk bid
01/18 BTG : U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's ..
01/17 TSX ends up as banks lead rally after rate hike
More sector news : Pharmaceuticals - NEC
Latest Tweets
01/08$TGTX: TG Therapeutics and Jiangsu Hengrui Medicine announce global license a.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
2017Oncolys Biopharma : Announces First Milestone from License Agreement with Jia.. 
More tweets
Qtime:31
Chart JIANGSU HENGRUI MEDICINE C
Duration : Period :
Jiangsu Hengrui Medicine C Technical Analysis Chart | 600276 | CNE0000014W7 | 4-Traders
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Average target price 76,9  CNY
Spread / Average Target 5,6%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou President & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO LTD6.61%32 088
JOHNSON & JOHNSON5.11%394 542
NOVARTIS1.02%227 089
PFIZER1.05%218 162
ROCHE HOLDING LTD.-5.33%211 361
MERCK AND COMPANY10.24%169 287